[Rifomycin in treatment of chronic tuberculosis with bacilli resistant to standard medications].
D000636:Aminosalicylic Acids / Q000627:therapeutic use; D002986:Clinical Trials as Topic; D004352:Drug Resistance, Microbial; D004357:Drug Synergism; D004977:Ethambutol / Q000627:therapeutic use; D006801:Humans; D012293:Rifampin / Q000627:therapeutic use*; D014376:Tuberculosis / Q000188:drug therapy*
D000636:Aminosalicylic Acids; D004977:Ethambutol; D012293:Rifampin
La rifampcine dans le traitement des tuberculoses chroniques à bacilles résistant aux médications standard.